Épisodes

  • Peptide Boom: FDA Loosening Rules, Market Hits $52.6B, What You Need to Know

    Peptide Boom: FDA Loosening Rules, Market Hits $52.6B, What You Need to Know
    Mar 19 2026
    In the past 48 hours, the biohacking industry shows momentum from regulatory shifts and product innovations, with RFK Jr. pushing to loosen FDA restrictions on nearly 20 peptides like ipamorelin, CJC-1295, BPC-157, and TB-500, potentially enabling U.S. compounding pharmacies to supply higher-quality versions and curb risky online imports.[1] This follows his recent Joe Rogan podcast comments, drawing support from physicians like Dr. Sue Decotiis for safer access under medical guidance, though experts caution on unproven safety and lack of human trials for many compounds.[1]

    Market data highlights growth: the global longevity ingredients sector, overlapping biohacking, hit $984.27 million in 2025 and projects $1,706.40 million by 2033 at 7.12% CAGR, with peptides and amino acids claiming 15% share; North America leads at 35%.[2] March 2026 saw spermidine supplements named U.S. award finalists for autophagy support and NAD+ injectable pens launch at wellness centers, signaling consumer shifts toward cellular repair tools.[2] Peptides overall reached a $52.6 billion market, with GLP-1 adoption at 1 in 8 U.S. adults.[8]

    New launches include U: The Mind Company's non-invasive brain device, an amplitude-modulated alternative to Neuralink, targeting focus and memory for biohackers; its Parkinson's trial is underway.[5] Weight-loss patches mimicking GLP-1 effects like Ozempic emerged as a 2026 trend, avoiding injections.[6]

    No major deals, disruptions, or price shifts reported in the last week, but leaders like Finnrick Analytics address supply impurities via testing.[1] Compared to early 2026's NAD+ gut health studies, current buzz amplifies peptides amid policy thaw, boosting influencer-driven demand without evident consumer pullback. Industry responds by prioritizing ethical sourcing and trials for credibility.[1][2] (298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    2 min
  • Biohacking Conferences 2026: From Optimization Fatigue to Invisible Health Tech

    Biohacking Conferences 2026: From Optimization Fatigue to Invisible Health Tech
    Mar 18 2026
    The biohacking industry shows steady momentum in the past 48 hours, driven by major conference announcements rather than market disruptions or new deals. On March 17, 2026, Biohackers World revealed plans for its March 28-29 Los Angeles event, expecting over 1,500 attendees, 35 speakers, and 75 exhibitors focused on longevity science, AI health data, microbiome research, and testable wellness tech like light therapies.[1] Similarly, Dave Asprey announced the speaker lineup for his 14th annual BEYOND Biohacking Conference on May 27-29 in Austin, featuring experts like Jay Shetty, Dr. Gabrielle Lyon, and Patrick Kennedy, with 150 exhibitors offering PEMF therapy, stem cells, and hyperbaric oxygen.[2][3]

    No verified market movements, price changes, partnerships, regulatory shifts, or supply chain issues emerged in the last week; data remains sparse. The global wellness economy, tied to biohacking, hit 5.6 trillion dollars in 2023 and is projected to reach 8.5 trillion by 2027, reflecting sustained growth in wearables and metabolic tracking.[1]

    Consumer behavior hints at a backlash against over-optimization, with fatigue from constant self-surveillance pushing toward "invisible care" tech that embeds health monitoring without screens, per 2026 wellness trends.[5] New product launches include Reaper's Remedies "Die Slower" vitamins on March 17, satirizing longevity hype in a crowded field.[7]

    Leaders like Asprey respond by expanding beyond protocols to consciousness and nervous system regulation, emphasizing meaningful life over mere lifespan extension.[2][3] Mick Safron of Biohackers World highlights a shift from quick fixes to structured, data-driven everyday health.[1] Compared to prior reporting, this builds on rising preventive health interest without major pivots, positioning Austin and LA as hubs amid no evident disruptions. Overall, the sector buzzes with events amid subtle consumer pushback on hyper-tracking.(298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    2 min
  • AI Biohacking Revolution: How Digital Biology and Luxury Wellness are Reshaping Health in 2026

    AI Biohacking Revolution: How Digital Biology and Luxury Wellness are Reshaping Health in 2026
    Mar 17 2026
    In the past 48 hours, the biohacking industry shows strong momentum driven by AI integration and luxury wellness demand. Nvidia CEO Jensen Huang highlighted digital biology as the next revolution, emphasizing AI for programmable biology and faster drug discovery, potentially slashing traditional 10 to 15 year timelines and 2 billion dollar costs.[1] This vision spotlights companies like Totaligent, which announced two binding Letters of Intent in February 2026 but gained fresh attention yesterday via market reports; one expands AI biologics via Aetherium acqui-hire, the other forms a joint venture with Japans GloMed Solutions, adding 10 million dollars annual revenue and 1 million in free cash flow from APAC clinics focused on peptides for metabolic and anti-aging therapies popular in biohacking.[1][2]

    New product buzz centers on the Ammortal Chamber, a 160,000 dollar home biohacking pod using red light, PEMF, and molecular hydrogen for inflammation reduction, ATP boost, and recovery; sessions start at 125 dollars, with elite athletes tracking gains via Oura Rings.[3] Upgrade Labs, an AI-driven fitness biohacking franchise, plans its Boulder, Colorado debut on March 27, expanding from California amid wellness booms.[4]

    Consumer shifts are evident: 60 percent of luxury buyers plan higher 2026 wellness spending in the 6.3 trillion dollar industry, fueling peptide injectables and cognitive programs like The Brain Song, reviewed March 15 for focus enhancement.[3][6] No major regulatory changes or disruptions reported, but supply chains strengthen via partnerships like Totaligents APAC push.

    Compared to prior weeks quieter news, this surge ties to Huangs comments, with leaders like Recursion Pharmaceuticals and Tempus AI leveraging Nvidia GPUs for data-heavy biohacks, reducing discovery from 42 to 18 months.[1] Biohacking evolves from niche to mainstream, blending AI precision with indulgent tech for longevity seekers. (298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    2 min
  • Biohacking Wellness Tourism: Thailand's $4.5 Trillion Ecosystem Revolution in 2026

    Biohacking Wellness Tourism: Thailand's $4.5 Trillion Ecosystem Revolution in 2026
    Mar 16 2026
    In the past 48 hours, the biohacking industry shows strong momentum in wellness tourism and performance optimization, with Thailand emerging as a key hub. On March 16, 2026, BDMS Wellness Clinic announced a major public-private alliance, partnering with biotech giants like Illumina and Abbott, the Tourism Authority of Thailand, and luxury providers to build a science-driven wellness ecosystem. This includes biohacking treatments, personalized diagnostics, and preventive care integrated with high-end travel, targeting Asias fast-growing wellness tourism sector amid a global 4.5 trillion wellness economy.[1]

    Consumer behavior shifts toward biohacking for work performance, as wearables like Whoop and Apple Watch track heart rate variability (HRV) to boost productivity. Tech workers in San Francisco compare HRV scores socially, while professionals in law and finance adopt infrared saunas, red light therapy, and continuous glucose monitors. Some limit rituals after observing over-optimization leading to burnout, reflecting AI-driven job anxieties.[3]

    New product integrations appear in luxury spas: The Longevity SPA at Lake Como EDITION launched biohacking therapies like Dry Float, Near Infra-Red, and Hydrogen Oxygen treatments for cellular regeneration, blending tech with holistic rituals.[6] No major deals, regulatory changes, or disruptions reported in the last week, but Thailand's initiative contrasts prior reporting by expanding biohacking beyond gadgets into tourism ecosystems, unlike isolated wearable trends.

    Leaders like BDMS respond to health tourism demand by orchestrating global partnerships, while execs like Dr. Ravi Solanki foster team biohacking culture for unity and performance. No verified stats from the past week beyond wellness economys scale, but growth signals sustained interest without price or supply chain shifts. This positions biohacking for broader accessibility in 2026.[1][3][6]

    (Word count: 298)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    2 min
  • Biohacking Boom 2026: AI Skin Tech, CGMs, and the Future of Longevity Wellness

    Biohacking Boom 2026: AI Skin Tech, CGMs, and the Future of Longevity Wellness
    Mar 13 2026
    In the past 48 hours, the biohacking industry shows robust momentum with innovation in wearables, funding wins, and expanding wellness applications, building on a market projected to hit 111 billion by 2034 from 28.2 billion in 2025.[1]

    Amorepacific earned a CES 2026 Innovation Award on March 12 for Skinsight, an AI-powered skin sensor patch tracking aging factors like tightness, UV exposure, and moisture, feeding data to a mobile app for personalized skincareits tech already boosted Sulwhasoo serum development.[2] This edges biohacking into beauty tech, converging with devices like Oura Rings and WHOOP straps for total health insights.[1][2]

    Funding highlights include Arya raising 21 million dollars on March 12 to scale its AI couples wellness platform, targeting relational longevity.[5] Wisp launched a women-focused Healthy Aging vertical, countering male-dominated biohacking by drawing females into longevity care.[5]

    Continuous glucose monitors (CGMs) spark debate as wellness trends, with over-the-counter FDA-cleared versions fueling biohacker optimization for metabolic health, though raising equity concerns for diabetes patients facing access barriers.[3] BioLongevity Labs released 2026 research peptides, amplifying DIY trends amid a peptides gold rush driven by influencers and GLP-1 hype, but safety questions linger.[6][7]

    No major regulatory shifts, deals, or disruptions emerged, but consumer behavior tilts toward accessible, data-driven toolsCGMs normalize on social media, and skin wearables promise real-world validation beyond labs.[2][3] Compared to prior reports, growth accelerates with womens entry and AI integration, versus male-centric clinics; US dermatology hit 10 billion in 2025 revenue, eyeing 3.1 percent CAGR through 2030.[2]

    Leaders like Amorepacific partner with MIT for scalable tech, addressing reliability challenges, while startups like Wisp respond to inclusivity gaps.[2][5] Supply chains hold steady, no price changes noted. The sector thrives on preventive promise amid aging populations. (298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    2 min
  • The Future of Biohacking: From Trend Ingredients to Accessible Wellness Formats in 2025

    The Future of Biohacking: From Trend Ingredients to Accessible Wellness Formats in 2025
    Mar 12 2026
    Based on the available search results from the past 48 hours, here is a current state analysis of the Biohacking industry:

    The biohacking market continues its robust expansion trajectory. Market valuations show the industry is estimated at USD 18.39 billion in 2025 and is projected to reach USD 44.65 billion by 2032, representing substantial compound annual growth. This sustained momentum reflects deepening consumer interest in optimization and cellular wellness strategies.

    Recent industry developments from Expo West 2026, held March 11, demonstrate significant shifts in product positioning and consumer demand. The market is moving decisively toward practical, routine-friendly supplement formats rather than abstract anti-aging claims. Longevity supplement trends are reframing around accessible benefit language including healthy aging, vitality, and cellular resilience, concepts directly fueled by biohacking culture.

    Key ingredient trends shaping current market dynamics include shilajit, which continues generating strong interest tied to male vitality and energy support categories. Shilajit benefits from substantial social media visibility but requires brands to address sourcing credibility, standardization, and compliant positioning to transition from trend-driven momentum to durable product development.

    Asian-inspired wellness ingredients are gaining premium positioning. Matcha demonstrated remarkable growth, posting 32,915 percent increase in cognitive health formulas year over year through December 2024. This positions matcha as a bridge between active nutrition, nootropics, and premium botanical energy platforms.

    The supplement delivery format landscape is evolving significantly. Coffee, tea, and hot cocoa are emerging as functional supplement delivery systems rather than standalone beverages. Consumer data indicates 38 percent of Gen Z want coffee with cognitive or mood benefits, while 35 percent seek relaxation or stress relief benefits.

    Multi-benefit positioning has become fundamental to market strategy. Mood support is expanding beyond niche applications, connecting to sleep, hydration, gut health, and everyday resilience. This platform positioning enables broader product development opportunities across multiple wellness categories.

    Industry leaders are responding to market shifts by emphasizing format innovation and accessibility. Soft chew sales rose 41 percent in 2024 according to SPINS data, signaling consumer preference for improved adherence and reduced pill fatigue. Products winning market share combine interesting ingredients with existing habit fit, strong sensory experience, and clear benefit storytelling rather than relying on ingredient novelty alone.

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    3 min
  • Biohacking Goes Mainstream: Regulatory Shifts and Market Boom in 2026

    Biohacking Goes Mainstream: Regulatory Shifts and Market Boom in 2026
    Mar 10 2026
    BIOHACKING INDUSTRY: 48-HOUR STATE ANALYSIS

    The biohacking sector continues its rapid expansion with significant developments emerging across regulatory, commercial, and consumer dimensions over the past two days.

    On the regulatory front, Washington State's proposed microchip implant ban has advanced substantially through the legislative process. The bill, which prohibits employers from mandating subcutaneous microchip implants containing personal identification data, now awaits Governor Bob Ferguson's signature. This legislation specifically targets implants used for tracking and identification purposes while exempting medical devices and wearable technology like smartwatches. The move reflects growing concern about potential labor abuses as biohacking technology accelerates, despite current limitations in available implant sophistication.

    Market demand remains robust. Magnesium threonate supplements, a biohacking-focused nootropic, experienced critical supply strain in early March 2026, with price gaps reaching 112 dollars between authentic and alternative products in Australia. This shortage follows repeated endorsements from prominent health and longevity podcasters, indicating strong consumer appetite for cognitive enhancement products.

    Industry leaders are actively scaling operations. David Rojas, founder of Blue Castle Ventures and Evocraft Labs, recently appeared on major media platforms including Fox5 and The Rhonda Swan Show, promoting commercially viable longevity platforms that combine biotechnology with human optimization services. His approach emphasizes translating advanced science into accessible systems for healthspan extension and performance enhancement across North America and Latin America.

    High-profile adoption continues gaining momentum. Daymond John, the Shark Tank investor, has publicly discussed his extensive biohacking protocols including extended fasting regimens, following his thyroid cancer diagnosis. His platform amplifies consumer interest in longevity optimization techniques.

    The sector is preparing for accelerated growth. The French Riviera will host the Côte d'Azur's first major international longevity and biohacking summit on March 12th, 2026, at Le Méridien Nice, underscoring increasing global attention to this emerging market.

    Current conditions show the biohacking industry transitioning from niche experimentation toward mainstream commercialization. While sophisticated neural interfaces remain limited to research trials, accessible biohacking products like RFID implants, nootropic supplements, and performance optimization platforms are entering broader consumer markets. The convergence of regulatory oversight, celebrity endorsement, and international conference activity suggests the sector is establishing legitimacy comparable to established wellness industries, potentially positioning it for the anticipated multi-billion dollar expansion noted by industry analysts.

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    Non communiqué
  • From Biohacker Bros to Mainstream Wellness: The 69 Billion Dollar Shift by 2030

    From Biohacker Bros to Mainstream Wellness: The 69 Billion Dollar Shift by 2030
    Mar 9 2026
    In the past 48 hours, the biohacking industry shows steady growth amid shifting consumer trends and brand pivots, valued at nearly 25 billion dollars currently and projected to hit 69 billion by 2030 per Grand View Research.[1][3] High-profile endorsements dominate headlines, with Shark Tank star Daymond John detailing his post-cancer routine of 40-hour fasts, cold plunges, red-light therapy, hyperbaric oxygen, and blood filtration treatments in a Fortune interview, emphasizing longevity over vanity.[3] He invests in Lotus for wearable data integration and Regenerate for UFC injectables, signaling elite adoption.

    Bulletproof, once the biohacking coffee pioneer under Dave Asprey, is rebranding away from extreme tech-bro vibes toward accessible wellness. New CEO Harry Lewis announced at Expo West a Coffee plus Creatine powder for Target in May and protein iced coffee at Sprouts, targeting Gen Z with GLP-1 support and functional add-ons like lion's mane. Innovation drove 5 percent of 2025 revenue, up from 0.5 percent in 2024, reversing sales declines as consumers shun niche "biohacker" labels for everyday energy and balance.[5]

    Skepticism emerges with critiques of influencer-hyped supplements like shilajit, touted as a testosterone booster but backed by one small, industry-funded study showing modest 90-day gains amid placebo drops, urging medical oversight.[7] A UK piece questions the unregulated wellness complex.[4]

    No major deals, regulatory shifts, or disruptions surfaced in the last week, but leaders like John and Bulletproof respond to backlash by prioritizing relatable outcomes over hype. Compared to prior reports, celebrity routines amplify visibility while brands broaden appeal, reflecting consumer moves from grind optimization to sustainable habits.[2][3][5] Overall, biohacking matures into mainstream longevity, with verified growth intact. (298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Voir plus Voir moins
    2 min